LINC00662 contributes to the progression and the radioresistance of cervical cancer by regulating miR‐497‐5p and CDC25A

It is reported that long intergenic non‐coding RNA 00662 (LINC00662) plays an oncogenic role in tumours. However, the mechanism of LINC00662 in regulating the progression and radiosensitivity of cervical cancer (CC) is not clear. In this study, quantitative real‐time polymerase chain reaction (qRT‐PCR) was adopted to detect LINC00662 and miR‐497‐5p expressions in CC tissues and cells. The expression of cell division cycle 25 A (CDC25A) in CC cells was examined by Western blot. CC cell proliferation was determined by cell counting kit‐8 (CCK‐8) and BrdU assays. The survival rate of CC cells was evaluated by colony formation assay under different doses of X‐ray irradiation. CC cell migration and invasion were probed by Transwell assay. Besides, the interactions between miR‐497‐5p and LINC00662, and miR‐497‐5p and the 3′UTR of CDC25A were verified by dual‐luciferase reporter assay, RIP assay, and RNA pull‐down experiments. We demonstrated that, LINC00662 expression was remarkably raised in CC tissues and cell lines. LINC00662 overexpression promoted proliferation, migration, invasion and radioresistance of CC cells, and LINC00662 knockdown inhibited the above malignant phenotypes of CC cells. In terms of mechanism, LINC00662 facilitated CC progression and radioresistance by adsorbing miR‐497‐5p and indirectly up‐regulating CDC25A expression. In a word, the LINC00662/miR‐497‐5p/CDC25A axis boosts proliferation and metastasis of CC cells and enhances the radioresistance of cancer cells. Significance of the study CC poses a threat to the health of women all over the world. In this study, we demonstrated for the first time that LINC00662 expression was remarkably raised in CC tissues and cells. Cellular experiments confirmed that LINC00662 facilitated cell proliferation, migration, invasion and radiation resistance through the miR‐497‐5p/CDC25A axis, which might be a promising target for CC treatments.